Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London cabbies launch £250m legal action against Uber

(Sharecast News) - Uber Technologies is facing legal action on behalf of more than 10,500 London black cab drivers, it was confirmed on Thursday. A group action was filed in the High Court by law firm Mishcon de Reya on behalf of the drivers, for losses they sustained between May 2012 and March 2018.

The claim alleges that the ride-hailing app misled Transport for London about how its operating system works, and as a result took business away from black cab drivers unlawfully.

Litigation manager RGL Management, which is acting as agent for the claimants, said each drivers claim was likely to be worth up to £25,000 each. Uber has denied all allegations against it.

In a statement, the US firm said: "These old claims are completely unfounded. Uber operates lawfully in London, is fully licensed by Transport for London and is proud to serve millions of passengers and drivers across the capital."

The black cab drivers first attempted to bring a claim against Uber in 2018, but the case was halted because of the pandemic.

Richard Leedham, partner and head of commercial disputes at Mishcon de Reya, said: "Uber has consistently failed to comply with the law that applies to private hire vehicles in London."

Garry White, one of the drivers involved in the action, said: "Uber seems to believe it is above the law and cabbies across London have suffered loss of earnings because of it. It is time they were held to account."

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.